Arguing about the evidence
Readers, Writers and Inscription Devices in Coronary Heart Disease Risk Assessment
Bibliographic Data
| ID | 2265733 |
|---|---|
| Authors | Catherine M Will, Catherine Will (0000-0001-7224-714X, University of Essex, corresponding author) |
| Year | 2005 |
| Volume | 27 |
| Issue | 6 |
| Pages | 780-801 |
| Publication date | 2005-09-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Sociology of Health & Illness (JOURNAL) |
| Journal identifiers | ISSN: 0141-9889 • E-ISSN: 1467-9566 |
| Publisher | Wiley (PUBLISHER • GB) |
| DOI | 10.1111/j.1467-9566.2005.00474.x |
| PMID | 16283899 |
| OpenAlex | W2004092779 |
| Language | EN |
| Citations received | 22 |
| References cited | 28 |
This paper examines the history of tools developed to assess an individual's risk of coronary heart disease. A close reading of the tools themselves is combined with an analysis of debates published in medical journals such as the British Medical Journal (BMJ) and The Lancet. These literary conversations between scientists and doctors reveal complex negotiations about the form and meaning of medical technologies that have yet to become fully 'stable'. Early tools were promoted as a response to the high cost of cholesterol-lowering drugs (statins), but came to embody broader attempts to shape medical practice. These include the promotion of what has been understood as evidence-based medicine and regulation by political and professional actors, as well as the spread of 'risk thinking' more generally. Despite having a central place in recent British guidelines and policy, there is a surprising variety of tools in circulation, and ongoing uncertainty about their use and value
Cardiology · Coronary heart disease · Meaning (existential) · Negotiation · Political science · Politics · Promotion (chess) · Psychotherapist · Public relations · Reading (process) · Sociology · Value (mathematics) · Variety (cybernetics) · Computer Science · Global Public Health Policies and Epidemiology · Health Systems, Economic Evaluations, Quality of Life · Law · Lipoproteins and Cardiovascular Health · Medicine · Psychology
Theorising Risk Work
Special Issue
Do-it-yourself heart health? 'Lay' practices and products for disease prevention
The silent killer in media stories
Conceptualising the experience of health risk
‘Prevention is better than cure, but …’
The experience of risk as ‘measured vulnerability
The rise of statins in Denmark
Is Evidence‐Based Organizational Innovation in the NHS a Chimaera – Or Just Elusive
Making sense of professional identities
Identifying Effectiveness in ''The Old Old
Risky Bodies, Drugs and Biopolitics
Diagnosis
Doing evidence-based medicine? How NHS managers ration high-cost drugs
Making information 'relevant
Genetic unexceptionalism
Beyond beliefs
Stem cells clinical trials for cardiac repair
Regulating medical bodies? The consequences of the 'modernisation' of the NHS and the disembodiment of clinical knowledge
Well, I knew this already' - explaining personal genetic risk information through narrative meaning-making
Overruling uncertainty about preventative medications
On social plasticity
| Unique citing works | 22 |
|---|---|
| Citations per year | 1,22 |
| Citation span | 2008 - 2022 (15) |
| Citation velocity | historical |
| Highly cited | No |
| Citation types | Neutral: 19 |